Skip to content

EBITDA at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
$34M-54.8%
Opko Health logo
Opko HealthOPK
-$28.82M+34.0%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$52.98M-147%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$12.88M+49.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$82.36M-31.0%
Merck & Co. logo
Merck & Co.MRK

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Gross profit$3.3M-52.0%
Operating income-$5.3M-136%
Net income-$3.5M-746%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total equity$151.6M-29.8%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%
Free cash flow-$8.7M-223%

Valuation

See full
Market cap$261.08M-44.3%
Enterprise value$116.11M-59.6%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Gross margin65.4%-11.2pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Calculated from SIGA Technologies’s reported figures.

$5.3Mebit+
$149.9KDepreciation Depletion & Amortization
=-$5.17M

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's EBITDA?
SIGA Technologies (SIGA) reported EBITDA of -$5.17M in Q1 2026.
How has SIGA Technologies's EBITDA changed year-over-year?
SIGA Technologies's EBITDA decreased by 139.9% year-over-year, from -$2.16M to -$5.17M.
What is the long-term trend for SIGA Technologies's EBITDA?
Over 3 years (2021 to 2024), SIGA Technologies's EBITDA has grown at a -7.7% compound annual growth rate (CAGR), from $89.59M to $70.52M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.